technetium tc 99m diphosphonate has been researched along with etidronate in 2 studies
| Studies (technetium tc 99m diphosphonate) | Trials (technetium tc 99m diphosphonate) | Recent Studies (post-2010) (technetium tc 99m diphosphonate) | Studies (etidronate) | Trials (etidronate) | Recent Studies (post-2010) (etidronate) |
|---|---|---|---|---|---|
| 230 | 10 | 16 | 2,819 | 510 | 432 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, MD; Martin-Simmerman, P; Mirkin, D; Provisor, A; Siddiqui, A | 1 |
| Endo, Y; Funayama, H; Kawamura, H; Oizumi, T; Sugawara, S; Yamaguchi, K | 1 |
2 other study(ies) available for technetium tc 99m diphosphonate and etidronate
| Article | Year |
|---|---|
Calcification and uptake of Tc-99m diphosphonates in neuroblastomas: concise communication.
Topics: Abdominal Neoplasms; Bone and Bones; Calcinosis; Diphosphonates; Etidronic Acid; Female; Homovanillic Acid; Humans; Infant; Male; Neuroblastoma; Organotechnetium Compounds; Radionuclide Imaging; Technetium; Technetium Compounds; Technetium Tc 99m Medronate; Thoracic Neoplasms; Vanilmandelic Acid | 1984 |
Osteonecrosis of the jawbones in 2 osteoporosis patients treated with nitrogen-containing bisphosphonates: osteonecrosis reduction replacing NBP with non-NBP (etidronate) and rationale.
Topics: Aged; Aged, 80 and over; Binding, Competitive; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Humans; Inflammation Mediators; Lipopolysaccharides; Mandibular Diseases; Nitrogen; Osteomyelitis; Osteonecrosis; Osteoporosis, Postmenopausal; Radionuclide Imaging; Radiopharmaceuticals; Risedronic Acid; Technetium Compounds; Tooth Extraction | 2010 |